Navigation Links
World-Renowned Vascular Surgeon to Conduct Training at Harvard Medical School Site on Non-Invasive Treatment of Veins

BOSTON, Dec. 9 /PRNewswire/ -- Brian Newman, MD, FRCS, will conduct two training sessions for medical professionals on the Veinwave(TM) system, a revolutionary system used by doctors around the world to non-invasively eliminate spider veins and telangiectasia.

Dr. Newman, an internationally-acclaimed vascular surgeon based in the United Kingdom, developed Veinwave(TM) as a safe, reliable, non-invasive treatment utilizing the principle of Unipolar Thermo-Coagulation (UTC). UTC utilizes proprietary technology to deliver the unique radio-frequency energy without the need for anesthesia. An independent six-year study from Georges Pompidou Hospital documents the safety and effectiveness of this proprietary system with no side effects.

The Advanced Training Session for vascular surgeons is by invitation only and will be held Friday, Dec. 11, at the CardioVascular Institute at Beth Israel Deaconess Medical Center. A second seminar is open to all physicians and is scheduled for Saturday, Dec. 12, 9 a.m. at the Boston Marriott Newton. The seminar will cover an overview of the Veinwave(TM) technology, review case studies and procedural techniques, and allow attendees to observe live patient treatments. There is no fee to attend, but space is limited. To register, contact Amy Easterly at (205) 427-9323.

The CardioVascular Institute (CVI) at Beth Israel Deaconess Medical Center, a teaching hospital of Harvard Medical School, is the first Boston health care organization to purchase the revolutionary Veinwave(TM) system. The CVI's vascular surgeons include Allen D. Hamdan, MD, Frank B. Pomposelli, MD, Marc Schermerhorn, MD, and Mark C. Wyers, MD. Patients may book appointments by contacting the CardioVascular Institute at the Lowry Medical Office Building, 110 Francis Street, Suite 5B, Boston, MA 02215 (617) 632-9959. For more information, visit

About Dr. Brian Newman, MD, FRCS

Dr. Brian Newman, MD, FRCS, is the developer of Veinwave(TM), a revolutionary medical device used by doctors around the world to eliminate spider veins on the legs and fine thread veins, known as telangiectasia. A General and Vascular Consultant Surgeon based in the UK, Dr. Newman graduated in medicine from Manchester University in 1968. In 1973 he became a fellow of The Royal College of Surgeons and obtained his M.D. in 1977. Dr. Newman worked as an NHS consultant general surgeon at the Royal Bolton Hospital and a number of private hospitals in the North West of England.

Since the late 1990s, Dr Newman has concentrated his work on non-invasive procedures for telangiectasia and spider veins. In July 2001, the Veinwave(TM) was launched in the UK. Since then, Dr. Newman has trained hundreds of surgeons and today over 1,000 systems are used every day worldwide.

About Veinwave(TM)

The Veinwave(TM) is the world's most advanced treatment for effective removal of unwanted spider veins and telangiectasia. Used for nearly a decade by over 1,000 physicians in Europe, Veinwave(TM) recently received 510k clearance from the FDA to market in the USA. Designed primarily for vascular surgeons, dermatologists and plastic surgeons, Veinwave(TM) uses a revolutionary process called Unipolar Thermo-Coagulation (UTC), wherein a unique localized energy is applied to the skin on top of the affected area, causing the vein walls to collapse and the vein to disappear instantly.

Vein removal with the Veinwave(TM) provides safe, quick, and dramatic reduction of unwanted veins on any skin type, including ethnic and dark-skinned individuals. The technology significantly minimizes pain and the risks of bruising, burning, scaring and pigmentation changes that are associated with alternative treatments such as lasers and other light based systems. As a result, Veinwave(TM) has become the treatment of choice for practitioners and patients alike, providing a relatively painless walk-in/walk-out procedure with no bandages nor post-procedure care. Patients can resume regular activities and normal sun exposure immediately following treatment. For more information, visit or call (205) 427-9323.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Dr. Brian Newman

SOURCE Veinwave

SOURCE Veinwave
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. World-Renowned Therapist Joins The Center for Children and Families In Its Work With the Nations Poorest Families
2. World-renowned bioengineers to record history of medical inventions
3. World-Renowned Scientists to Lead Immunology Course
4. World-Renowned Physicians Converge on Methodist Dallas Medical Center for Largest Live Demonstration of Its Kind in Texas
5. World-Renowned Urologist, J. Francois Eid, M.D., Expands Practice with Increased Treatment of Benign Prostate Hyperplasia (BPH)
6. World-renowned Instructor of the Healing Practice of Qigong to Teach in Los Angeles Mar. 7 & 8
7. World-Renowned Golf Instructor David Leadbetter Promotes VaNu
8. World-renowned neuroscientist visits UTSA on May 5 to discuss the quest for consciousness
9. World-Renowned Neuroscientist Dr. Candace Pert will be Featured Speaker at the Chopra Center's Signature Mind-Body Healing Workshop in San Diego
10. World-renowned nanotechnology expert proves there is big potential in the smallest of matter
11. Tickets on Sale Now for World-Renowned Bodies...The Exhibition At Mall of America(R)
Post Your Comments:
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... will provide scholarships for people struggling with eating disorders as a result of ... the second annual event, held at Fox Run Golf Club in Eureka, will ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... that it has undertaken significant expansion of its current state of the art ... part of PharmaTech’s strategy to increase its manufacturing capacity as well as to ...
(Date:11/25/2015)... ... November 25, 2015 , ... Bcureful—a ... (TSC), as well as raising public awareness of the disorder while helping to ... third donation of $35,000 to bolster progress at the Tuberous Sclerosis Complex Center ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... treatment, is offering lower prices in an early celebration of the early holiday ... promotional price of $29.95 each (normally $33.95 ea). Black Friday promotional pricing is ...
(Date:11/24/2015)... , ... November 24, 2015 , ... Dr. Todd S. ... offer laser services to many of his patients. Dr. Afferica now uses the BIOLASE ... reduce the amount of time the doctor uses other traditional cutting tools, such as ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... LYON , Frankreich, November 25, 2015 ... hat heute bekanntgegeben, dass sie eine Lizenz für das ... Inserm, Poxel, CNRS, UCBL und ENS-Lyon innehaben, an Enyo ... 2009 von FUI AAP8 ins Leben gerufenen und von ... NATHEB-Programms wurde FXR als ein Behandlungsziel für HBV identifiziert, ...
(Date:11/24/2015)... 24, 2015  Natera, Inc. (Nasdaq: ... testing and the analysis of circulating cell-free ... at the 27 th  Annual Piper Jaffray ... p.m. ET.  Matthew Rabinowitz, Ph.D., CEO of Natera, ... activities and financial outlook.  ...
(Date:11/24/2015)... COMMACK, New York , 24. November ... Hersteller des Avery Breathing Pacemaker Systems, ist ... Ph.D., als Clinical Consultant bekannt geben zu ... -->   --> ... Stockholm (Schweden). Von 1984-1986 ...
Breaking Medicine Technology: